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CASE REPORT
Levonorgestrel intrauterine system 
embedded within tubal ectopic pregnancy: 
a case report
Dorothy Makena* , Ingrid Gichere and Khadija Warfa
Abstract 
Background: The presence of the levonorgestrel-releasing intrauterine system embedded within an ectopic preg-
nancy is a rare occurrence. Tubal migration of an intrauterine device is not well understood and has not been exten-
sively studied in literature.
Case presentation: A 34-year-old African woman, para 1, gravida 2, presented with symptoms of ruptured ectopic 
pregnancy. She underwent a laparoscopy where a ruptured left ectopic pregnancy was found with a levonorgestrel-
releasing intrauterine system inserted 2 years prior embedded within the tube. A left salpingectomy was performed 
with removal of the levonorgestrel-releasing intrauterine system. The patient recovered well and proceeded to have 
an intrauterine pregnancy 3 months later.
Conclusion: Migration of the levonorgestrel-releasing intrauterine system into the fallopian tube is a rare occurrence 
that is not well understood. In the case presented, levonorgestrel-releasing intrauterine system was found embedded 
within the fimbrial end of the left fallopian tube, which had a ruptured ectopic pregnancy. Surgical treatment with 
laparoscopy is recommended for intraabdominal intrauterine device to prevent complications.
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Background
An intrauterine contraceptive device (IUD) is a highly 
effective method of contraception [1]. Types of IUDs 
include the levonorgestrel releasing intrauterine system 
(LNG IUS), also commonly referred to as Mirena, and 
the copper IUD. They have a low failure rate of less than 
1%, which is comparable to permanent sterilization [1]. 
The pearl index of the LNG IUS is 0.06 per 100 women 
years, while that of the copper IUD is 0.52 per 100 
women years [2]. Even though the risk of ectopic preg-
nancy with IUDs is lower than with no contraception, 
if a pregnancy occurs with an IUD in situ, it is likely to 
be an ectopic pregnancy. The rate of ectopic pregnancy 
among LNG IUS users ranges from 0.02 to 0.2 per 100 
women years, whereas the rate among copper IUD users 
ranges from 0.1 to 0.8 per 100 women years. In case of 
pregnancy, the risk of ectopic pregnancy is higher in 
LNG IUS users compared with copper IUD users (27% 
versus 15% respectively) [2]. Progesterone is known to 
cause ciliary dysfunction within the fallopian tube, sub-
sequently predisposing LNG IUS users who conceive to 
ectopic pregnancy [3]. It is therefore important to rule 
out ectopic pregnancy in women with acute abdomen or 
positive pregnancy test among LNG IUS users [4]
A correctly positioned IUD is located within 3  mm 
of the uterine fundus, with both arms extending to the 
cornua, a vertically oriented stem in the uterine body, 
and the strings protruding through the cervical os into 
the vaginal canal [5]. Suboptimally placed IUDs are at a 
higher risk of malposition or expulsion and associated 
Open Access
*Correspondence:  maksdot@gmail.com
Department of Obstetrics and Gynecology, Aga Khan University Hospital 
Nairobi, P.O. Box 30270-00100, Nairobi, Kenya
Page 2 of 6Makena et al. J Med Case Reports          (2021) 15:107 
symptoms [5]. Malposition of IUDs is a common compli-
cation of this method of contraception, with a reported 
rate of up to 10% [6]. Malposition of an IUD includes 
displacement, expulsion, rotation, or embedment. Migra-
tion of IUDs is, however, an uncommon occurrence, 
with most cases of migration reported to the colon and 
the urinary tract [7–9]. The fallopian tube is an uncom-
mon location for migration and embedment [7]. Having 
an IUD embedded within a tubal ectopic pregnancy is an 
even rarer phenomenon.
We describe a case of a patient who presented with 
ruptured ectopic pregnancy and was found to have a 
LNG IUS embedded in the fimbrial end of the affected 
fallopian tube.
Case presentation
A 34-year-old African female, para 1, gravida 2, presented 
to the Accident and Emergency Department, having had 
symptoms of vomiting and abdominal pain for 3 days. 
The symptoms had worsened on the day of presentation 
to the hospital. She reported several episodes of vomiting 
with associated loose stools and abdominal fullness. She 
also had ongoing vaginal bleeding that had started 5 days 
prior to presentation.
Two years prior, the patient had an uncomplicated 
insertion of LNG IUS by an obstetrician/gynecologist at 
the 8-week visit following a normal vaginal delivery. She 
had a normal pap smear done at the time of insertion. 
One year following insertion, she had a desire to conceive 
and was scheduled for removal of the LNG IUS device. 
The strings could not be seen, and the device could not 
be retrieved with alligator forceps. The patient was there-
fore sent for a pelvic ultrasound to locate the lost IUD. 
The device was not seen on ultrasound. The patient was, 
however, lost to follow-up until presentation with symp-
toms of ruptured ectopic pregnancy. She had no preexist-
ing conditions or previous surgery.
On physical examination she was in fair general condi-
tion and not pale. Her vital signs were a temperature of 
37.6 °C, a blood pressure of 120/66 mmHg, pulse rate of 
99 beats per minute, respiration rate of 18 breaths per 
minute, and oxygen saturation of 100% on room air. On 
abdominal examination she had tenderness on the left 
iliac fossa and suprapubic regions with absent bowel 
sounds. The rest of the systemic examination was nor-
mal. An impression of acute abdomen was made at this 
point. As initial treatment she was given intravenous 
fluids (Ringer’s lactate solution) 1-L bolus, as well as 
intravenous paracetamol and ondansetron for pain and 
vomiting, respectively.
The initial investigations included a full blood count, 
which revealed a normal hemoglobin level of 13.2 g/dl, 
slightly elevated white cell count of 12.28 ×  109 cells/L, 
and normal platelet count of 314 × 109 cells/L. She had a 
beta human chorionic gonadotropin (Hcg) level of 7721 
mIU/ml. Urinalysis showed leucocytes 2+, nitrite nega-
tive, and blood 2+. Transvaginal ultrasound showed a 
2.1 cm × 1.8 cm echogenic mass with central cystic area 
on the left adnexa. It had no internal or peripheral vascu-
larity. There was marked pelvic echogenic free fluid with 
low internal echoes extending to the Morrison’s pouch. 
The uterus was anteverted and normal in size and shape 
with an endometrial thickness of 5.5 mm. A 1.9 cm cystic 
lesion was seen in the right ovary, which was likely a cor-
pus luteum cyst. There was no gestational sac or intrau-
terine device seen within the endometrial cavity (Fig. 1). 
These features indicated ruptured ectopic pregnancy.
The diagnosis at this point was a ruptured left tubal 
ectopic pregnancy. The plan was to admit the patient for 
an emergency laparoscopy with possible left salpingec-
tomy. The diagnosis and plan were explained to the 
patient, who signed an informed consent for the proce-
dure. Group and cross match of one unit of packed red 
cells was ordered in case a transfusion would be required.
The laparoscopy was done under general anesthesia 
in the Lloyd–Davis position. Cohen’s uterine manipula-
tor was placed. Veress insufflation was performed, fol-
lowed by insertion of a 10-mm primary trocar at the 
umbilicus. Entry and operating pressures were 20 mmHg 
and 15  mmHg, respectively. Two secondary ports were 
inserted under vision, 5  mm in the right iliac fossa and 
12  mm in the left iliac fossa. On primary survey, LNG 
IUS was found embedded at the fimbrial end of the left 
fallopian tube (Fig. 2). The LNG IUS was retrieved whole 
under vision through the 12-mm port (Fig. 3). There was 
hemoperitoneum of 700 ml (Fig. 2). A ruptured left amp-
ullary ectopic pregnancy was identified by left salpingec-
tomy using bipolar coagulation and scissors (Fig.  4). A 
corpus luteum cyst was found on the right ovary with 
normal right fallopian tube. Suction and peritoneal lav-
age were performed, and hemostasis was confirmed 
(Fig. 5). The specimen was retrieved through the 12-mm 
port and taken for histology. There was no sign of uterus 
perforation. The pouch of Douglas and rectum appeared 
normal. All trocars were removed under vision.
The postoperative recovery of the patient was unre-
markable. She was debriefed about the surgery and dis-
charged the following morning. She went home on oral 
paracetamol and diclofenac for pain relief.
The patient was reviewed in the gynecology outpatient 
clinic 2 weeks later. She was asymptomatic and doing 
well. Histology report confirmed left ectopic tubal gesta-
tion. She reported that she desired conception. Precon-
ception counseling was done. She was put on daily folic 
acid (400 µg). The patient was advised to come to the hos-
pital as soon as she missed a period or tested positive for 
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pregnancy for an early pregnancy ultrasound to rule out 
another ectopic pregnancy. Three months later she pre-
sented at the early pregnancy clinic following 5 weeks of 
amenorrhea. A pelvic ultrasound was done that showed 
intrauterine pregnancy at 5 weeks gestation.
Discussion
The above case documents a rare occurrence of a rup-
tured ectopic pregnancy with the LNG IUS embedded 
within the affected fallopian tube.
Levonorgestrel IUS (Mirena) is a safe, reversible, and 
highly effective contraceptive method [2]. It is known 
to have other therapeutic benefits such as reduction in 
menstrual bleeding, anemia, and dysmenorrhea, as well 
as management of endometrial hyperplasia [10]. In this 
patient, the use of the LNG IUS was purely for contracep-
tion purposes.
Ectopic pregnancies affect approximately 2% of all 
pregnancies. The most common presentation of an 
ectopic pregnancy is abdominal pain and abnormal 
uterine bleeding [11]. Even though the rate of ectopic 
Fig. 1 Ultrasound image of an empty uterus. The arrow points to the endometrial lining measuring 5.5 mm
Fig. 2 Body of the embedded LNG IUS (indicated by arrow), which is seen protruding from the left tubal pregnancy with hemoperitoneum
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pregnancy is lower in women using LNG IUS, if a preg-
nancy occurs while using this IUD, there is a high risk 
of it being an ectopic pregnancy [2]. Current IUD use is 
a known risk factor for ectopic pregnancy [12]. Other 
risk factors for ectopic pregnancy include pelvic inflam-
matory disease, previous tubal surgery, previous ectopic 
pregnancy, and smoking [12]. On examination, features 
of acute abdomen due to hemoperitoneum may be pre-
sent [11, 12]. The patient in this case had a presenta-
tion suggestive of ectopic pregnancy with concurrent 
LNG IUS use as a risk factor. However, she had other 
unspecific presenting features of diarrhea, vomiting, and 
low-grade fever. It is important to note that some patients 
may be asymptomatic without specific risk factors for an 
ectopic pregnancy [12]
On the other hand, malposition of an IUD is one of its 
common complications, presenting with pelvic pain and 
bleeding or no symptoms [13]. Although malposition is 
associated with reduced contraceptive efficacy, this is 
mostly true for copper IUDs and not LNG IUS, which has 
local progesterone effects [6]. Malposition is diagnosed 
by ultrasound [13]. However, compared with copper 
Fig. 3 LNG IUS (indicated by arrow) being retrieved from the left tubal pregnancy
Fig. 4 Left salpingectomy (indicated by arrow) performed using bipolar coagulation
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IUDs, the LNG IUS is more likely to be missed by ultra-
sonography. LNG IUS is compounded with barium sul-
fate, which makes it radio opaque for X-ray recognition 
[14]. A plain X-ray can therefore be used as an adjunctive 
imaging modality in the case of a lost LNG IUS not seen 
on ultrasound [15]. The patient in this case had a lost 
LNG IUS not seen on ultrasound 1 year after insertion 
but was lost to follow-up for additional imaging.
Uterine perforation is uncommon, with an incidence of 
1 in 1000 insertions. It is a serious complication of IUD 
use and is often asymptomatic [16]. There is increased 
risk of perforation if insertion is done less than 6 months 
postpartum or while breastfeeding. This period is asso-
ciated with endometrial atrophy with accelerated uterine 
involution and hence has a high risk of perforation [6, 
13]. The current patient was asymptomatic for malposi-
tion or perforation for 2 years prior to the ectopic preg-
nancy. The transvaginal ultrasound done at diagnosis of 
ectopic pregnancy did not visualize the device in the left 
adnexa. Her LNG IUS was inserted only 2 months post-
partum while breastfeeding. This may have been a risk 
factor for possible unrecognized perforation.
Routine transvaginal ultrasound to monitor IUD posi-
tion either immediately post insertion or after 6 weeks 
is not recommended without clinical suspicion of mal-
position according to de Kroon et  al. [17]. It has been 
reported that IUDs take approximately 3 months to set-
tle into their stable position. An initially malpositioned 
IUD can therefore assume the correct fundal position 
over time [18]. In asymptomatic women with uncom-
plicated IUD insertion, routine ultrasound lacks ben-
efit over clinical evaluation with string check at 6 weeks 
[17]. The patient in this case was asymptomatic without 
complications at insertion. One year later, the LNG IUS 
device could not be seen on clinical examination nor on 
ultrasound.
The mechanism of device migration is not well under-
stood, especially in the case of tubal migration. The fal-
lopian tube is a rare site for dislocated IUD [19, 20]. This 
phenomenon has been described in few case reports. 
There are theories from case reports about the tubal 
migration of an IUD. The first possibility is placement 
of the device at the tubal ostium during insertion with 
subsequent migration into the tube due to uterine con-
tractions and tubal peristalsis [21]. The other possibility 
is uterine perforation with migration of the device into 
the peritoneal cavity and subsequent perforation of a pre-
existing hydrosalpinx as described by Ozdemir et  al. in 
a case report [19]. The patient in this case did not have 
any hydrosalpinx noted intraoperatively. Perforation 
can be due to either immediate traumatic perforation at 
insertion or delayed transmural migration [22, 23]. It is 
also possible that, following an unrecognized perfora-
tion, there was nestling of the IUD close to the fimbrial 
end of the fallopian tube, with the device being envel-
oped within the fimbria [7, 19]. This phenomenon could 
have occurred antecedent to conception of the ectopic 
pregnancy. In the patient in this case, there was no sign 
of uterus perforation. The pouch of Douglas and rectum 
appeared normal.
The presence of an IUD within the fallopian tube is 
associated with an inflammatory reaction [19] interfer-
ing with tubal function and predisposing the patient to 
ectopic pregnancy. The tubal dysfunction is exacerbated 
Fig. 5 Pelvic view after completion of the procedure confirming hemostasis. Arrow points to an empty pouch of Douglas
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by progesterone in the LNG IUS, which interferes with 
ciliary beating and tubal contractility [3]. It is possible 
that the embedment of LNG IUS at the fimbrial end of the 
fallopian tube occurred as a result of displacement from 
the proximal tube by the growing tubal pregnancy or its 
rupture.
Once an intraabdominal IUD is diagnosed, it should 
be removed whether it is symptomatic or not to avoid 
serious complications such as adhesion formation, 
bowel obstruction, and infertility [15, 19]. Laparoscopy 
is the surgical approach of choice as it is safe and effec-
tive. It provides good visualization to locate and remove 
a lost IUD [15]. In this case, the diagnosis of the LNG 
IUS within the fallopian tube and its removal were done 
laparoscopically.
Conclusion
Migration of the LNG IUS into the fallopian tube is a 
rare occurrence that is not well understood. In the case 
presented, a LNG IUS was found embedded within the 
fimbrial end of the fallopian tube that had a ruptured 
ectopic pregnancy. Surgical treatment with laparoscopy 
is recommended for intraabdominal IUD to prevent 
complications. The patient made a good recovery and 
proceeded to have an intrauterine pregnancy 3 months 
later, as desired.
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